Evidence map›Paper›PMID 32134398›Full record

ArticleThe Journal of clinical investigation2020

Ventromedial hypothalamic nucleus neuronal subset regulates blood glucose independently of insulin.

Jonathan N Flak, Paulette B Goforth, James Dell'Orco, Paul V Sabatini, Chien Li, Nadejda Bozadjieva, Matthew Sorensen, Alec Valenta, Alan Rupp, Alison H Affinati and 8 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 68 citations in OpenAlex.

  1. Review
  2. ParabrachialProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Projection-defined hypothalamic outputs differentially regulate thermogenesis and lipolysis.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. Hypothalamus-liver talks: whispers in the language of metabolism.Reviews in endocrine & metabolic disorders · 2026
    Review
  5. PVNJournal of neuroinflammation · 2026
    Article
  6. Article
  7. A Preoptic Neurocircuit That Modulates Metabolic Flexibility.bioRxiv : the preprint server for biology · 2026
    Article
  8. Brain Nutrient Sensing: A Unifying Framework.Annual review of physiology · 2026
    Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 2 institutions in 1 country.

Jonathan N FlakDepartment of Internal Medicine and.
Paulette B GoforthDepartment of Pharmacology, University of Michigan, Ann Arbor, Michigan, USA.
James Dell'OrcoDepartment of Internal Medicine and.
Paul V SabatiniDepartment of Internal Medicine and.
Chien LiNovo Nordisk, Seattle, Washington, USA.
Nadejda BozadjievaDepartment of Surgery.
Matthew SorensenDepartment of Chemistry, and.
Alec ValentaDepartment of Chemistry, and.
Alan RuppDepartment of Internal Medicine and.
Alison H AffinatiDepartment of Internal Medicine and.
Corentin Cras-MéneurDepartment of Internal Medicine and.
Ahsan AnsariDepartment of Internal Medicine and.
Jamie SacksnerDepartment of Internal Medicine and.
Nandan KodurDepartment of Internal Medicine and.
Darleen A SandovalDepartment of Surgery.
Robert T KennedyDepartment of Chemistry, and.
David P OlsonDivision of Endocrinology, Department of Pediatrics, University of Michigan, Ann Arbor, Michigan, USA.
Martin G MyersDepartment of Internal Medicine and.
University of Michigan · USNovo Nordisk (United States) · US

Funding

PUBLIC HEALTH DEMONSTRATIONP60DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MYERS, MARTIN G · 1985 to 2012
$26.5M
Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DAVID P OLSON · 2013 to 2026
$24.3M
University of Michigan Center for Gastrointestinal ResearchP30DK034933 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI OMARY, BISHR · 1986 to 2021
$22.5M
Pilot and Feasibility (P and F) ProgramP30DK089503 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Kanakadurga Singer · 2010 to 2026
$20.3M
MOLECULAR DETERMINANTS OF LEPTIN RECEPTOR/JAK2 SIGNALINGR01DK056731 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MYERS, MARTIN G · 1999 to 2025
$6.0M
Postdoc Stipend Supplement: Developmental Origins of Metabolic Disorders T32T32DK071212 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DAVID P OLSON, Kanakadurga Singer · 2005 to 2026
$5.4M
In vivo chemical monitoring using capillary separationsR37EB003320 · NIBIB · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KENNEDY, ROBERT T · 2008 to 2017
$3.6M
MICROELECTRODE AND MICRODIALYSIS-BASED INSULIN SENSORSR01DK046960 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KENNEDY, ROBERT T · 1993 to 2020
$3.3M
Design and Use of Methods for Peptide Secretion Studies - Diversity SupplementR37DK046960 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KENNEDY, ROBERT T · 2006 to 2015
$3.0M
In vivo chemical monitoring using capillary separationsR01EB003320 · NIBIB · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KENNEDY, ROBERT T · 2003 to 2020
$2.7M
Unique Roles for Defined PVH Neurons in the Control of Energy BalanceR01DK104999 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI OLSON, DAVID P · 2016 to 2020
$2.5M
Role of Glucokinase in GLP-1 Regulation of Energy and Glucose HomeostasisR01DK082480 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SANDOVAL, DARLEEN A. · 2010 to 2014
$1.7M
NIBIB NIH HHS R01 EB003320NIBIB NIH HHS R37 EB003320NIDDK NIH HHS F32 DK122660NIDDK NIH HHS P30 DK020572NIDDK NIH HHS P30 DK034933NIDDK NIH HHS P30 DK089503NIDDK NIH HHS P60 DK020572NIDDK NIH HHS R01 DK046960NIDDK NIH HHS R01 DK056731NIDDK NIH HHS R01 DK082480NIDDK NIH HHS R01 DK104999NIDDK NIH HHS R25 DK088752NIDDK NIH HHS R37 DK046960NIDDK NIH HHS R56 DK104999NIDDK NIH HHS T32 DK071212
6 · The paper itself

Abstract

To identify neurons that specifically increase blood glucose from among the diversely functioning cell types in the ventromedial hypothalamic nucleus (VMN), we studied the cholecystokinin receptor B-expressing (CCKBR-expressing) VMN targets of glucose-elevating parabrachial nucleus neurons. Activation of these VMNCCKBR neurons increased blood glucose. Furthermore, although silencing the broader VMN decreased energy expenditure and promoted weight gain without altering blood glucose levels, silencing VMNCCKBR neurons decreased hIepatic glucose production, insulin-independently decreasing blood glucose without altering energy balance. Silencing VMNCCKBR neurons also impaired the counterregulatory response to insulin-induced hypoglycemia and glucoprivation and replicated hypoglycemia-associated autonomic failure. Hence, VMNCCKBR cells represent a specialized subset of VMN cells that function to elevate glucose. These cells not only mediate the allostatic response to hypoglycemia but also modulate the homeostatic setpoint for blood glucose in an insulin-independent manner, consistent with a role for the brain in the insulin-independent control of glucose homeostasis.

Indexed as

AnimalsBlood GlucoseFemaleInsulinMaleMiceMice, TransgenicNeuronsVentromedial Hypothalamic NucleusBlood GlucoseInsulinEndocrinologyGlucose metabolismMetabolismNeuroendocrine regulation

Identifiers

PMID32134398
PMCPMC7260001
OpenAlexW3009322884

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.